Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients

More than half of high-risk neuroblastoma (NB) patients have experienced relapse due to the activation of chemoresistant minimal residual disease (MRD) even though they are treated by high-dose chemotherapy with autologous peripheral blood stem cell (PBSC) transplantation. Although MRD in high-risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Nino, Nanako, Ishida, Toshiaki, Nakatani, Naoko, Lin, Kyaw San, Win, Kaung Htet Nay, Mon, Cho Yee, Nishimura, Akihiro, Inoue, Shotaro, Tamura, Akihiro, Yamamoto, Nobuyuki, Uemura, Suguru, Saito, Atsuro, Mori, Takeshi, Hasegawa, Daiichiro, Kosaka, Yoshiyuki, Nozu, Kandai, Nishimura, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578974/
https://www.ncbi.nlm.nih.gov/pubmed/36276741
http://dx.doi.org/10.1016/j.heliyon.2022.e10978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578974/
https://www.ncbi.nlm.nih.gov/pubmed/36276741
http://dx.doi.org/10.1016/j.heliyon.2022.e10978

Ejemplares similares